{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:25:20Z","timestamp":1761017120423,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ahj.2015.07.025","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T11:16:39Z","timestamp":1437909399000},"page":"753-759.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial"],"prefix":"10.1016","volume":"170","clinical-trial-number":[{"clinical-trial-number":"nct01425359","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Suzanne V.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren K.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio E.","family":"Inzucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Belardinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard R.","family":"Chaitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ahj.2015.07.025_bb0005","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.1971.03190220020005","article-title":"Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results","volume":"218","author":"Goldner","year":"1971","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ahj.2015.07.025_bb0010","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/eurheartj\/ehr077","article-title":"Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study","volume":"32","author":"Schramm","year":"2011","journal-title":"Eur Heart J"},{"issue":"9593","key":"10.1016\/j.ahj.2015.07.025_bb0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials","volume":"370","author":"Lago","year":"2007","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ahj.2015.07.025_bb0020","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ahj.2015.07.025_bb0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2015.07.025_bb0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11886-009-0038-4","article-title":"Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs","volume":"11","author":"Gore","year":"2009","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"10.1016\/j.ahj.2015.07.025_bb0035","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ahj.2015.07.025_bb0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jc.2012-3042","article-title":"Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes","volume":"98","author":"Currie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ahj.2015.07.025_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diabres.2008.09.004","article-title":"Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case\u2013control study","volume":"82","author":"Sadikot","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.ahj.2015.07.025_bb0050","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00125-011-2084-x","article-title":"Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study","volume":"54","author":"Mellbin","year":"2011","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ahj.2015.07.025_bb0055","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.ahj.2015.07.025_bb0060","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.amjcard.2012.04.061","article-title":"Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus","volume":"110","author":"Patil","year":"2012","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2015.07.025_bb0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/2047487314533622","article-title":"Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study","volume":"22","author":"Arnold","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ahj.2015.07.025_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2261-6-41","article-title":"The impact of diabetes on one-year health status outcomes following acute coronary syndromes","volume":"6","author":"Peterson","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.ahj.2015.07.025_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.81.4.352","article-title":"Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population","volume":"81","author":"Brown","year":"1999","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ahj.2015.07.025_bb0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/heart.87.2.140","article-title":"Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population","volume":"87","author":"Brorsson","year":"2002","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ahj.2015.07.025_bb0085","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCOUTCOMES.108.829523","article-title":"Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial","volume":"2","author":"Arnold","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"20","key":"10.1016\/j.ahj.2015.07.025_bb0090","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9713","key":"10.1016\/j.ahj.2015.07.025_bb0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"Currie","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ahj.2015.07.025_bb0105","doi-asserted-by":"crossref","first-page":"H1883","DOI":"10.1152\/ajpheart.00617.2006","article-title":"Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning","volume":"292","author":"Schmidt","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9131","key":"10.1016\/j.ahj.2015.07.025_bb0110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ahj.2015.07.025_bb0115","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ahj.2015.07.025_bb0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315004652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315004652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:54:55Z","timestamp":1757570095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870315004652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0002870315004652"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2015.07.025","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2015.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}